Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2125)
All Articles published online
|
Oct 28, 2007 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Uygur-Bayramiçli O, Dabak R, Orbay E, Dolapçıoğlu C, Sargın M, Kılıçoğlu G, Güleryüzlü Y, Mayadağlı A. Type 2 dıabetes mellıtus and CA 19-9 levels. World J Gastroenterol 2007; 13(40): 5357-5359 [PMID: 17879406 DOI: 10.3748/wjg.v13.i40.5357] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i40/5357.htm |
| Number | Citing Articles |
| 1 |
Qi-cai LIU, Feng GAO, Qi-shui OU, Ze-hao ZHUANG, Shou-rong LIN, Bin YANG, Zu-jian CHENG. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis. Chinese Medical Journal 2008; 121(2): 108 doi: 10.1097/00029330-200801020-00003
|
| 2 |
Yu-Cheng Cheng, Yu-Hsuan Li, Chiann-Yi Hsu, I-Te Lee. <p>Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 1933 doi: 10.2147/DMSO.S256223
|
| 3 |
Ayman A. Zayed, Abdallah M. Beano, Farah N. Amer, Jumana M. Maslamani, Mohammad A. Zmaili, Talha H. Al-Khudary, Munther S. Momani, Al-Motassem F. Yousef. Serum Levels of Carcinoembryonic Antigen in Patients with Type 2 Diabetes. Endocrine Practice 2016; 22(11): 1310 doi: 10.4158/EP161221.OR
|
| 4 |
Kamile Gul, Sevinc Nas, Didem Ozdemir, Reyhan Ersoy, Bekir Cakir, Mehmet Gumus. CA 19-9 Level in Patients With Type 2 Diabetes Mellitus and Its Relation to the Metabolic Control and Microvascular Complications. The American Journal of the Medical Sciences 2011; 341(1): 28 doi: 10.1097/MAJ.0b013e3181f0e2a0
|
| 5 |
Manal Abudawood, Hajera Tabassum, Basmah Almaarik, Ali Aljohi. Interrelationship between oxidative stress, DNA damage and cancer risk in diabetes (Type 2) in Riyadh, KSA. Saudi Journal of Biological Sciences 2020; 27(1): 177 doi: 10.1016/j.sjbs.2019.06.015
|
| 6 |
Sunyoung Kim, Byung Kyu Park, Jeong Hun Seo, Jinyoung Choi, Jong Won Choi, Chun Kyon Lee, Jae Bock Chung, Yongjung Park, Dong Wook Kim. Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65720-8
|
| 7 |
Sundeep Singh, Shou-jiang Tang, Jayaprakash Sreenarasimhaiah, Luis F. Lara, Ali Siddiqui. The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma. Digestive Diseases and Sciences 2011; 56(8): 2491 doi: 10.1007/s10620-011-1709-8
|
| 8 |
Masanori Shimodaira, Tomohiro Niwa, Koji Nakajima, Mutsuhiro Kobayashi, Norinao Hanyu, Tomohiro Nakayama. The Relation between CA 19-9 level and Early-Phase Insulin Secretion in Normoglycemic and Prediabetic Subjects. The International Journal of Biological Markers 2015; 30(2): 169 doi: 10.5301/jbm.5000130
|
| 9 |
Jae Hyun Lee, Dong-Kun Kim, Mi-Yeon Lee, Han-Sol Lim, Min-Jung Kwon, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park. The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults. Nutrients 2023; 15(15): 3394 doi: 10.3390/nu15153394
|
| 10 |
Tian Tao KUANG, Da Yong JIN, Dan Song WANG, Xue Feng XU, Xiao Ling NI, Wen Chuan WU, Wen Hui LOU. Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: Data from a single institution in China. Journal of Digestive Diseases 2009; 10(1): 26 doi: 10.1111/j.1751-2980.2008.00359.x
|
| 11 |
Hongmin Xu, Lei Zhang, Hua Kang, Jie Liu, Jiandong Zhang, Jie Zhao, Shuye Liu, Francesca Coperchini. Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis. International Journal of Endocrinology 2021; 2021: 1 doi: 10.1155/2021/9990768
|
| 12 |
Jolanda Stiksma, Diana C. Grootendorst, Peter Willem G. van der Linden. CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer. Clinical Colorectal Cancer 2014; 13(4): 239 doi: 10.1016/j.clcc.2014.09.004
|
| 13 |
Rui Du, Wanwan Sun, Lin Lin, Jichao Sun, Kui Peng, Yu Xu, Min Xu, Yuhong Chen, Yufang Bi, Weiqing Wang, Donghui Li, Jieli Lu. Serum CA 19-9 and risk of incident diabetes in middle-aged and elderly Chinese: a prospective cohort study. Acta Diabetologica 2017; 54(2): 201 doi: 10.1007/s00592-016-0937-y
|
| 14 |
Farzaneh Karimi, Negar Dinarvand, Mohammad Sabaghan, Omid Azadbakht, Shima Ataee, Ebrahim Kharazinejad, Mostafa Moazamfard. Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis. Endocrine 2023; 83(1): 1 doi: 10.1007/s12020-023-03477-6
|
| 15 |
Sun Hee Kim, Cho-ok Baek, Kyung Ae Lee, Tae Sun Park, Hong Sun Baek, Heung Yong Jin. Clinical implication of elevated CA 19-9 level and the relationship with glucose control state in patients with type 2 diabetes. Endocrine 2014; 46(2): 249 doi: 10.1007/s12020-013-0058-0
|
| 16 |
Zhaoyang Li, Jing Wang, Xu Han, Fei Wang, Hua Hu, Jing Yuan, Ping Yao, Sheng Wei, Huan Guo, Dan Zheng, Yuhan Tang, Handong Yang, Meian He. Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study. Journal of Diabetes Investigation 2020; 11(3): 585 doi: 10.1111/jdi.13166
|
| 17 |
Shrey Modi, Devika Kir, Ashok Kumar Saluja. Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer. Gastroenterology 2021; 160(4): 1019 doi: 10.1053/j.gastro.2021.01.001
|
| 18 |
Limei Cui, Naqiang Lv, Bin Li, Jing Tao, Xiaomin Zheng, Yehua Yan, Cuiping Liu. Serum CA 19–9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes 2021; 129(08): 581 doi: 10.1055/a-0994-9970
|
| 19 |
Reversible high blood CEA and CA19-9 concentrations in a diabetic patient. Libyan Journal of Medicine 2012; 7(1): 19572 doi: 10.3402/ljm.v7i0.19572
|
| 20 |
Yinfang Tu, Haoyong Yu, Pin Zhang, Jianzhong Di, Xiaodong Han, Songhua Wu, Yuqian Bao, Weiping Jia. Decreased serum CA19‐9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux‐en‐Y gastric bypass. Journal of Diabetes Investigation 2014; 5(6): 694 doi: 10.1111/jdi.12200
|
| 21 |
Sang Pyo Lee, In-Kyung Sung, Jeong Hwan Kim, Sun-Young Lee, Hyung Seok Park, Chan Sup Shim. Usefulness of Carbohydrate Antigen 19-9 Test in Healthy People and Necessity of Medical Follow-up in Individuals with Elevated Carbohydrate Antigen 19-9 Level. Korean Journal of Family Medicine 2019; 40(5): 314 doi: 10.4082/kjfm.18.0057
|
| 22 |
Reiko Yamada, Junya Tsuboi, Yumi Murashima, Takamitsu Tanaka, Kenji Nose, Hayato Nakagawa. Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions. Biomedicines 2023; 11(6): 1687 doi: 10.3390/biomedicines11061687
|
| 23 |
Adrianne Tsen, Mary Barbara, Laura Rosenkranz. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology 2018; 18(8): 862 doi: 10.1016/j.pan.2018.09.004
|
| 24 |
Yutaka J. Kawamura, Aika Tokumitsu, Junichi Sasaki, Shingo Tsujinaka, Takafumi Maeda, Ken Mizogami, Fumio Konishi. Colorectal Carcinoma with Extremely Low CA19-9. Gastroenterology Research and Practice 2009; 2009: 1 doi: 10.1155/2009/780263
|
| 25 |
Nina J Karlin, Shailja B Amin, Heidi E Kosiorek, Matthew R Buras, Patricia M Verona, Curtiss B Cook. Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus. Future Science OA 2018; 4(4): FSO291 doi: 10.4155/fsoa-2017-0144
|
| 26 |
Jun Murai, Sumiko Soga, Hiroshi Saito, Michio Otsuki, Takatoshi Kitada, Yoshifumi Saisho, Hideji Nakamura, Soji Kasayama, Masafumi Koga. Study on the mechanism causing elevation of serum CA19-9 levels in diabetic patients. Endocrine Journal 2013; 60(7): 885 doi: 10.1507/endocrj.EJ12-0364
|
| 27 |
|
| 28 |
Erfan Amini, Farhad Pishgar, Asal Hojjat, Mohammad Soleimani, Majid Ali Asgari, Abdol-Mohammad Kajbafzadeh. The role of serum and urinary carbohydrate antigen 19-9 in predicting renal injury associated with ureteral stone. Renal Failure 2016; 38(10): 1626 doi: 10.1080/0886022X.2016.1202732
|
| 29 |
Francesca Tavano, Andrea Fontana, Tommaso Mazza, Domenica Gioffreda, Tommaso Biagini, Orazio Palumbo, Massimo Carella, Angelo Andriulli. Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01567
|
| 30 |
Naim Ata, Kürşat Dal, Metin Kucukazman, Abdullah Ö. Yeniova, Serdar Karakaya, Oktay Unsal, Murat Dagdeviren, Kadir O. Akın, Salih Baser, Esin Beyan, Derun T. Ertugrul. The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels. Open Medicine 2014; 10(1) doi: 10.1515/med-2015-0002
|
| 31 |
Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay, Priyabrata Mukherjee. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Advanced Drug Delivery Reviews 2010; 62(3): 346 doi: 10.1016/j.addr.2009.11.007
|
| 32 |
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Alessandra Rando, Mario Uccello, Francesco Basile, Antonio Biondi, Santo Carnazzo, Innocenza Alessandria, Clorinda Mazzarino. Markers of bile duct tumors. World Journal of Gastrointestinal Oncology 2011; 3(4): 49-59 doi: 10.4251/wjgo.v3.i4.49
|
| 33 |
Da-Hye Son, Hye Sun Lee, Yong-Jae Lee. Association between serum carbohydrate antigen 19-9 levels and leukoaraiosis in middle-aged and older adults: A cross-sectional study. Atherosclerosis 2020; 292: 188 doi: 10.1016/j.atherosclerosis.2019.11.003
|
| 34 |
Yuanfu Qiu, Jian He, Xinliang Chen, Pinbo Huang, Kaishun Hu, Haiyan Yan. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma. Clinica Chimica Acta 2018; 480: 186 doi: 10.1016/j.cca.2018.02.008
|
| 35 |
Yun HUANG, Yu XU, Yufang BI, Min XU, Jieli LU, Tiange WANG, Mian LI, Yuhong CHEN, Yu LIU, Fei HUANG, Baihui XU, Jie ZHANG, Weiqing WANG, Guang NING. Relationship between CA 19‐9 levels and glucose regulation in a middle‐aged and elderly Chinese population. Journal of Diabetes 2012; 4(2): 147 doi: 10.1111/j.1753-0407.2011.00179.x
|
| 36 |
Qingqu Guo, Muxing Kang, Bo Zhang, Ying Chen, Xin Dong, Yulian Wu. Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. Journal of Cancer Research and Clinical Oncology 2010; 136(11): 1627 doi: 10.1007/s00432-010-0820-0
|
| 37 |
Songyan Zhang, Chengming Sun, Wenping Zhou. Electrochemical Immunoassay Determination of a Cancer Biomarker (CA19-9) by Horseradish Peroxidase. International Journal of Electrochemical Science 2017; 12(9): 8447 doi: 10.20964/2017.09.31
|
| 38 |
Xiaofen Wen, Donatella Coradduzza, Jiaxin Shen, Antonio Mario Scanu, Maria Rosaria Muroni, Matteo Massidda, Vincenzo Rallo, Ciriaco Carru, Andrea Angius, Maria Rosaria De Miglio. Harnessing Minimal Residual Disease as a Predictor for Colorectal Cancer: Promising Horizons Amidst Challenges. Medicina 2023; 59(10): 1886 doi: 10.3390/medicina59101886
|
| 39 |
Ji Yang Kim, Se Hyung Kim, Soo Young Kim. Elevated serum CA 19-9 at screening tests: underlying conditions and role of abdominopelvic CT. European Radiology 2014; 24(10): 2435 doi: 10.1007/s00330-014-3262-2
|
| 40 |
María Sancho-Albero, Víctor Sebastián, Javier Sesé, Roberto Pazo-Cid, Gracia Mendoza, Manuel Arruebo, Pilar Martín-Duque, Jesús Santamaría. Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer. Journal of Nanobiotechnology 2020; 18(1) doi: 10.1186/s12951-020-00701-7
|
| 41 |
Gaetano Bertino, Annalisa Maria Ardiri, Giuseppe Stefano Calvagno, Giulia Malaguarnera, Donatella Interlandi, Marco Vacante, Nicoletta Bertino, Francesco Lucca, Roberto Madeddu, Massimo Motta. Carbohydrate 19.9 Antigen Serum Levels in Liver Disease. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/531640
|
| 42 |
Marco La Torre, Giuseppe Nigri, Annalisa lo Conte, Federica Mazzuca, Simone Maria Tierno, Adelona Salaj, Paolo Marchetti, Vincenzo Ziparo, Giovanni Ramacciato. Is a Preoperative Assessment of the Early Recurrence of Pancreatic Cancer Possible after Complete Surgical Resection?. Gut and Liver 2014; 8(1): 102 doi: 10.5009/gnl.2014.8.1.102
|
| 43 |
S. L. Ong, A. Sachdeva, G. Garcea, G. Gravante, M. S. Metcalfe, D. M. Lloyd, D. P. Berry, A. R. Dennison. Elevation of Carbohydrate Antigen 19.9 in Benign Hepatobiliary Conditions and Its Correlation with Serum Bilirubin Concentration. Digestive Diseases and Sciences 2008; 53(12): 3213 doi: 10.1007/s10620-008-0289-8
|
| 44 |
Dóra Illés, Viktória Terzin, Gábor Holzinger, Klára Kosár, Richárd Róka, Gábor Zsóri, György Ábrahám, László Czakó. New-onset type 2 diabetes mellitus – A high-risk group suitable for the screening of pancreatic cancer?. Pancreatology 2016; 16(2): 266 doi: 10.1016/j.pan.2015.12.005
|
| 45 |
Sayo Kawai, Koji Suzuki, Kazuko Nishio, Yoshiko Ishida, Rieko Okada, Yasuyuki Goto, Mariko Naito, Kenji Wakai, Yoshinori Ito, Nobuyuki Hamajima. Smoking and serum CA19‐9 levels according to Lewis and secretor genotypes. International Journal of Cancer 2008; 123(12): 2880 doi: 10.1002/ijc.23907
|
| 46 |
Hye-Ryoun Kim, Chang-Hyun Lee, Young Whan Kim, Sung Koo Han, Young-Soo Shim, Jae-Joon Yim. Increased CA 19-9 level in patients without malignant disease. Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.152
|
| 47 |
Omer Burcak Binicier, Zehra Betul Pakoz. CA 19-9 levels in patients with acute pancreatitis due to gallstone and metabolic/toxic reasons. Revista da Associação Médica Brasileira 2019; 65(7): 965 doi: 10.1590/1806-9282.65.7.965
|
| 48 |
Shuichi Okada, Junichi Okada, Koji Kikkawa, Eijiro Yamada, Kazuya Okada, Kihachi Ohshima. Patients with Type 2 Diabetes Mellitus Accompanied by Elevated Serum CA19-9 Associated Not with Pancreatic Cancer but Interstitial Lung Disease. Dubai Diabetes and Endocrinology Journal 2022; 28(2): 65 doi: 10.1159/000524603
|
| 49 |
Erdem Kocak, Seyfettin Köklü, Erdem Akbal. Extreme High Serum Level of Carbohydrate Antigen 19-9 in a Patient with a Single Biliary Stone. The American Surgeon 2010; 76(12): 1429 doi: 10.1177/000313481007601236
|
| 50 |
Jung Wan Choe, Hyo Jung Kim, Jae Seon Kim, Jaehyung Cha, Moon Kyung Joo, Beom Jae Lee, Jong-Jae Park, Young-Tae Bak. Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes. Hepatobiliary & Pancreatic Diseases International 2018; 17(3): 263 doi: 10.1016/j.hbpd.2018.04.001
|
| 51 |
B. Juntermanns, G. M. Kaiser, S. Itani Gutierrez, M. Heuer, M. Buechter, A. Kahraman, H. Reis, S. Kasper, A. Paul, C. D. Fingas. CA19-9 beim intrahepatischen Cholangiokarzinom. Der Chirurg 2018; 89(6): 466 doi: 10.1007/s00104-018-0636-z
|
| 52 |
Leela R. Jaidev, Laxmi S. Chede, Hemanth K. Kandikattu. Theranostic Nanoparticles for Pancreatic Cancer Treatment. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(2): 203 doi: 10.2174/1871530320666200516164911
|
| 53 |
Byoungjin Park, Yong-Jae Lee. Association of serum carbohydrate antigen 19-9 level with arterial stiffness and coronary artery calcification in middle-aged and older adults. Journal of Hypertension 2020; 38(1): 95 doi: 10.1097/HJH.0000000000002217
|
| 54 |
Kirti Magudia, Christine O. Menias, Sanjeev Bhalla, Venkata S. Katabathina, Jeffrey W. Craig, Mark M. Hammer. Unusual Imaging Findings Associated with Germ Cell Tumors. RadioGraphics 2019; 39(4): 1019 doi: 10.1148/rg.2019180050
|
| 55 |
Razieh Sangsari, Kayvan Mirnia, Maryam Saeedi, NinaGozali Asl, Abdol-Mohammad Kajbafzadeh. Prognostic value of carbohydrate antigen 19-9 in the urine of mothers with fetal hydronephrosis to the severity and cause of neonatal renal involvement. Journal of Clinical Neonatology 2022; 11(3): 143 doi: 10.4103/jcn.jcn_6_22
|
| 56 |
Haoyong Yu, Ruixia Li, Lei Zhang, Haibing Chen, Yuqian Bao, Weiping Jia. Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients. Experimental Diabetes Research 2012; 2012: 1 doi: 10.1155/2012/745189
|
| 57 |
Rui Du, Di Cheng, Lin Lin, Jichao Sun, Kui Peng, Yu Xu, Min Xu, Yuhong Chen, Yufang Bi, Weiqing Wang, Jieli Lu, Guang Ning. Association between serum CA 19‐9 and metabolic syndrome: A cross‐sectional study. Journal of Diabetes 2017; 9(11): 1040 doi: 10.1111/1753-0407.12523
|